Overview

An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if an investigational drug is safe and efficacious for poorly controlled type 2 diabetes mellitus.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company